Skip to content
Screener

SG&A at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$107.6M-22.0%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$86.18M+6.5%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$88M+1.1%

Other financials

Income statement

See full
Revenue$5.8M+11.0%
Gross profit$5.5M+19.2%
Operating income-$52.2M-19.0%
Net income-$81.1M-115%
EPS (diluted)-$1.22-76.8%

Balance sheet

See full
Cash & equivalents$413.0M+62.8%
Total debt$62.8M-5.8%
Total equity$324.1M+8,195%
Total assets$985.1M+68.4%

Cash flow

See full
Operating cash flow-$28.6M+28.4%
CapEx$472.0K+81.5%
Free cash flow-$29.0M+27.7%

Valuation

See full
Market cap$3.15B+325%
Enterprise value$2.8B+406%
P/S168.5×+117×

Profitability

See full
Gross margin92.5%+4.6pp
Operating margin-1,071.5%-90.6pp
Net margin-1,350.7%-35.3pp
FCF margin-864.7%-194pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.2×
Current ratio10×0.0×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The source filing: uniQure’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 7:17 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-087815
Line itemThree months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
Operating expenses:
Cost of license revenues(350)(656)(569)(853)
Research and development expenses(33,964)(35,383)(63,140)(71,523)
Selling, general and administrative expenses(17,367)(13,500)(37,435)(24,408)
Total operating expenses(51,681)(49,539)(101,144)(96,784)
Other income1,5982,5973,23010,903
Other expense(7,961)(2,185)(9,412)(4,144)
Loss from operations(52,203)(43,865)(97,923)(83,196)

Item 1.Financial Statements

FAQ

What is uniQure's SG&A?
uniQure (QURE) reported SG&A of $17.37M in Q2 2026.
How has uniQure's SG&A changed year-over-year?
uniQure's SG&A increased by 28.6% year-over-year, from $13.5M to $17.37M.
What is the long-term trend for uniQure's SG&A?
Over 4 years (2021 to 2025), uniQure's SG&A has grown at a 4.1% compound annual growth rate (CAGR), from $55.66M to $65.46M.
What does SG&A mean?
Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Ask your AI about uniQure's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude